Boston Scientific Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2013
Total Assets: $16.57B
Liabilities Breakdown FY2013
Total Liabilities: $10.03B
Asset Breakdown
Total Assets: $16.57B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $217.0M | 1.3% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $897.0M | 5.4% |
| Property, Plant & Equipment | $1.55B | 9.3% |
| Goodwill | $5.69B | 34.4% |
| Intangible Assets | $5.95B | 35.9% |
| Other Assets | $2.27B | 13.7% |
Liabilities Breakdown
Total Liabilities: $10.03B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $246.0M | 2.5% |
| Long-Term Debt | $4.20B | 41.9% |
| Other Liabilities | $5.59B | 55.7% |